Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |